Future of the Travel Vaccines Market: Strategic Analysis and Forecast to 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Travel Vaccines Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the market for travel vaccines has seen substantial development in the past few years. Its growth is forecasted to increase from $4.73 billion in 2024 to $5.09 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this progress in the past are heightened international travel, health initiatives by the government for travelers, the global spread of diseases, rising awareness among travelers, and the growth in the travel and tourism sector.

Travel Vaccines Market Size Forecast: What's the Projected Valuation by 2029?
The market for travel vaccines is projected to exhibit significant expansion in the forthcoming years, with an estimated value reaching "$7.36 billion by 2029". This corresponds to an annual compound growth rate (CAGR) of 9.6%. Factors leading to this uptick include the escalating trend of business travels, a rise in threats from emerging infectious diseases, distinct government policies and entrance prerequisites, a growing preference for offbeat travel locations, and government and pharmaceutical alliances. The forecast period also sees trends like the adoption of personalized immunization strategies, market proliferation into non-endemic areas, embracement of digital healthcare technology, regulatory backing and simplified authorizations, as well as novelty in developments.

View the full report here:
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

What Are the Drivers Transforming the Travel Vaccines Market?
The expansion of the travel vaccine market is predicted to be driven by the surge in travel and tourism. Travel and tourism entail the transportation of individuals or items, encompassing vehicles such as ships, planes, trains, and other modes, across disparate geographical regions. Providing safety and health protection for tourists and travelers throughout their overseas journeys, travel vaccines serve a critical role. For example, the United Nations World Tourism Organization (UNWTO), an intergovernmental institution dedicated to promoting tourism, based in Spain, reported in January 2023 that over 900 million tourists ventured internationally in 2022. This figure is twice that of 2021 and 63% higher than pre-pandemic levels. Consequently, the growth in travel and tourism is acting as a catalyst for the expansion of the travel vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

What Long-Term Trends Will Define the Future of the Travel Vaccines Market?
The trend of product innovation is seeing a surge in the travel vaccine market. Key companies within the market are creating novel vaccines to maintain their foothold. For instance, in August 2022, Indonesia's National Agency for Drug and Food Control approved Takeda Pharmaceutical Company Limited, a pharmaceutical entity based in Japan, for QDENGA (Dengue Tetravalent Vaccine) (TAK-003), a vaccine designed to prevent dengue fever induced by any serotype in individuals between six and 45 years old. The vaccine demonstrated that, post-immunization for three years, it continued to offer comprehensive protection against dengue and related hospitalization, independent of an individual's prior exposure to the disease.

Which Segments in the Travel Vaccines Market Offer the Most Profit Potential?
The travel vaccines market covered in this report is segmented -

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel

Subsegments:
1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines
2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)
3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines
4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine
5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines
6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine
7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)
8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine
9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11918&type=smp

Which Firms Dominate the Travel Vaccines Market by Market Share and Revenue in 2025?
Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

Which Regions Offer the Highest Growth Potential in the Travel Vaccines Market?
North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11918

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.